If Marc is Suzanne’s father, does it follow that Suzanne is his child?

By Daniela Cutas, Anna Smajdor, Kristien Hens, and Emma Moormann According to the respondents in our study, the short answer is: not necessarily. We drafted a series of vignettes in which we explored the relationships between reproduction, genes, and parenthood. We wanted to understand the impact that the degree of genetic relatedness might have on […]

Read More…

Expanding the mind and rights of patients with implantable BCIs

By Guido Cassinadri and Marcello Ienca Implantable brain-computer interfaces (iBCI) are implantable systems that record quantitative neural data and use them to deliver various responses such as therapeutic, diagnostic, or preventive interventions. BCIs have been used inter alia to predict seizures in epileptic patients by monitoring their neural data and either delivering electrical stimulation or […]

Read More…

Mind the anticipatory gap: factoring future moral change into the governance of human genome editing

By John Danaher. Human genome editing is a potentially transformative emerging technology. Current clinical trials of CRISPR, for example, suggest it can be used as a therapeutic to treat a wide range of hereditary and acquired diseases. More speculatively, it could also be used as an enhancer, improving the capacities of generally normal or healthy […]

Read More…

Making visible the invisible elements of clinical ethics consultation

By Clare Delany, Sharon Feldman, Barbara Kameniar, and Lynn Gillam. In our article, ‘Making clinical ethics facilitation visible and accessible: Seven steps of the Critical Dialogue method of Ethics Consultation’, we detail our method of clinical ethics facilitation, broken down into seven steps. We also share the rationale for the various steps, and provide concrete […]

Read More…

There is no health on a dead planet

By Rammina Yassaie and Lucy Brooks Our paper “Reassessing ‘Good’ Medical Practice and the Climate Crisis” takes an ethical dive into the roles and responsibilities of the medical profession and the medical regulator, in light of the climate and ecological crisis and its profound implications for health. The health sector has been called to action […]

Read More…

Interdisciplinary collaboration to identify and address ethical issues arising from the development of irreversible, high risk medical treatments

By Alex Harris & Frederic Gilbert. There are increasing numbers of clinical trials assessing high risk, irreversible treatments.  While a clinical trial aims to assess the safety and efficacy of a clinical intervention, participants enrolled in trials of high risk, irreversible treatments may be left with significant ongoing or emerging burdens after exiting the trial. […]

Read More…

Thoraco-Abdominal Normothermic Regional Perfusion: Can the dead “beheaded” donor be killed?

By Christos Lazaridis. Thoraco-abdominal normothermic regional perfusion (TA-NRP) is a relatively novel technique for donation after the circulatory determination of death (DCDD). In short, after declaration of death by circulatory criteria (as in conventional DCDD), the circulation to the brain is surgically excluded followed by extracorporeal membrane oxygenation (ECMO) and perfusion of the thoracoabdominal organs. […]

Read More…